Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.1490
Abstract: Key Points Question Are frontline therapies recommended for malignant pleural mesothelioma (MPM) associated with patient benefits? Findings In this comparative effectiveness study of 1501 participants, the statistical robustness of the Mesothelioma Cisplatin Pemetrexed Study (MPS),… read more here.
Keywords: malignant pleural; clinical trials; frontline therapies; pleural mesothelioma ... See more keywords